Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.
about
Sero-prevalence and incidence of A/H1N1 2009 influenza infection in Scotland in winter 2009-2010Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, FrancePrevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USAEpidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study.Seroprevalence to influenza A(H1N1) 2009 virus--where are we?Influenza pandemic epidemiologic and virologic diversity: reminding ourselves of the possibilities.Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility.Anti-Human H1N1pdm09 and swine H1N1 Virus Antibodies among Swine Workers in Guangdong Province, China.Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strainsInfection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A PandemicPrevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemicEpigenetic and Transcriptomic Regulation of Lung Repair during Recovery from Influenza Infection.Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United StatesSeroprevalence of pandemic (H1N1) 2009 in pregnant women in China: an observational study.Did modeling overestimate the transmission potential of pandemic (H1N1-2009)? Sample size estimation for post-epidemic seroepidemiological studiesIndividual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccinationSeroepidemiologic study of pandemic (H1N1) 2009 during outbreak in boarding school, EnglandHigh incidence of severe influenza among individuals over 50 years of age.Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 Southern hemisphere countries.Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan.Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.Prevalence of influenza A (H1N1) seropositivity in unvaccinated healthcare workers in Scotland at the height of the global pandemic.Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.H1N1v at a seroepidemiological glance: is the nightmare over?Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice.Evaluation of the seroprevalence of influenza A(H1N1) 2009 on a university campus: a cross-sectional study.Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, MongoliaInfluenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients.Progress in structure-based drug design against influenza A virus.Vaccine allocation in a declining epidemic.Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains.Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemicEpidemiological and virological characterization of 2009 pandemic influenza A virus subtype H1N1 in Madagascar.
P2860
Q21560815-FBCB6FAB-7211-4F7C-9AC4-2C0DC70D402DQ28730980-65E32A94-DAB2-4551-A0A7-1D6328AD298AQ28741061-2D1BEADB-36AD-44DE-82CE-889F442BC431Q28742786-4CEAB3B1-C63E-463B-BB6D-D2C39BB9CCFEQ30223476-9E3E14B5-0C21-43BF-8FCB-7F11732E0F87Q30224919-609AF68C-B5A4-4ECE-B29F-C18A7B8CBC18Q30226505-A556808E-6938-4D62-9454-E661DF97A4EDQ30226546-1C5B1DA3-8931-41F9-91C4-238011F5906DQ30226708-2315771C-AB51-49A6-B5A1-F5A3E44EE26DQ30354383-7171FDB5-ABA3-497D-BBBC-B5DB242C0DF0Q30377091-2C699CA3-45D0-4EAA-A580-971DD2FFDEE1Q30382895-D2C5AB29-AD1C-44D7-8BD9-8D1EF964F0AAQ30383772-5B88E5B4-EA64-4D15-94BB-77EC109E2809Q30394995-85788A86-8524-4E73-A816-EAD598F326A6Q30395289-BE2A9BDD-2A95-4CF4-81A3-10F478554308Q30398550-70162BFA-8ABD-48A9-8CA3-DC7A3D13ACA3Q30401049-2A33C2AA-16F3-4961-87CF-FCF823573063Q30401153-C59EA805-B595-4795-90B3-D2A2AAE7DACFQ30401351-575DC11A-50C3-49B8-BC88-54D5DD708638Q30404512-34EFA9AD-342B-4C5E-A519-CAB72F4881ECQ30406109-7B027B66-1D14-43B9-9B1E-26110432FC25Q30406692-BE3ABBA2-1B0F-42D3-B27A-7E428C5B56F4Q30406838-BBA61BE2-EF0D-40A6-B0AE-F93C0335B238Q30406967-69B0607D-8817-44A5-BEC4-DF2066DD71B6Q30406971-EEF6A35C-1671-46E1-ABC5-C18AC0961BB5Q30407047-85D29433-2D42-4292-8A57-EBE1938AB6E8Q30407863-98933DBE-3D1C-437F-A048-76DB1BD787B7Q30407929-A033C400-405D-43AA-9B2C-5295958EFB87Q30409115-63FDB7DA-0A58-4EAE-B06B-6E1EEF0FCAA2Q30410129-1B5E8680-0612-4B98-94EA-4E15F2BD89FDQ30410600-FFB6704A-129E-4800-BE79-56AC944FBDB4Q30412979-6BBC7A67-A225-4B7D-A84D-7000E3D4AF3DQ30413007-FDAAFCF9-86DA-46EE-BD01-33D3805DC295Q30413677-35DD1916-A881-44B9-8D6E-47BE658504E5Q30414286-BF509CB2-D2BF-4609-9A29-82C02CE48915Q30417369-388D75C3-B29E-4C87-B2DF-A6786318B874Q30418929-928B4289-A140-4FF8-B302-F5D3095AF0FBQ30419472-94E2C3FB-619D-4676-93E0-5C90B5006F3FQ30423135-8E9D3303-1391-4ECF-BBD3-E1CBC8F814BEQ30423849-CF8240AA-682D-47FF-AAC1-856684461FAA
P2860
Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@ast
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@en
type
label
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@ast
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@en
prefLabel
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@ast
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@en
P2093
P2860
P1433
P1476
Seroprevalence following the s ...... luenza in Pittsburgh, PA, USA.
@en
P2093
Brendan M Giles
Corey J Crevar
Donald M Carter
Donald S Burke
James H Stark
Shanta M Zimmer
Stephen M Ostroff
Ted M Ross
P2860
P304
P356
10.1371/JOURNAL.PONE.0011601
P407
P577
2010-07-14T00:00:00Z